The Enterprise Value as of June 2026 (TTM) for Lisata Therapeutics, Inc. (LSTA) is 19.36M

According to Lisata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.36M. This represents a change of 74.70% compared to the average of 11.08M of the last 4 quarters.

Lisata Therapeutics, Inc. (LSTA) Historical Enterprise Value (quarterly & annually)

How has LSTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Lisata Therapeutics, Inc. over the last ten years is 7.26M. The current 19.36M Enterprise Value has changed 26.58% with respect to the historical average. Over the past ten years (40 quarters), LSTA's Enterprise Value was at its highest in in the June 2021 quarter at 83.31M. The Enterprise Value was at its lowest in in the December 2022 quarter at -19111345.00.

Lisata Therapeutics, Inc. (LSTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lisata Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lisata Therapeutics, Inc. (LSTA) Average Enterprise Value

How has LSTA Enterprise Value performed in the past?

The current Enterprise Value of Lisata Therapeutics, Inc. (LSTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lisata Therapeutics, Inc. (LSTA) Enterprise Value vs. Peers

How is LSTA’s Enterprise Value compared to its peers?

Lisata Therapeutics, Inc.’s Enterprise Value is greater than MetaVia Inc. (-9706480.00), greater than NuCana plc (-12018987.12), greater than Enlivex Therapeutics Ltd. (14.92M), greater than Passage Bio, Inc. (-8943624.00), greater than Exicure, Inc. (15.14M), greater than CASI Pharmaceuticals, Inc. (18.28M), less than Clearside Biomedical, Inc. (56.30M), less than Pelthos Therapeutics Inc. (38.54M), greater than Klotho Neurosciences, Inc. (13.75M), greater than CollPlant Biotechnologies Ltd. (2.53M),

Build a custom stock screener for Lisata Therapeutics, Inc. (LSTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lisata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lisata Therapeutics, Inc. (LSTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lisata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.